Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of MORAb-004 in patients with solid tumors
jRCT2080222023Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ontuxizumab in Non-hematologic malignancy, sponsored by Eisai Co., Ltd.
02
Drugs
ontuxizumab
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080222023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222023.